Broadcom Stock On a Rise; Does the Recovery Have Enough Behind It to Retest the All-Time High?

Broadcom stock is rebounding after a sharp five-week sell-off that pulled AVGO nearly 30% below its all-time high of $481.57. The stock fell despite reporting 143% year-over-year AI chip revenue growth, guiding Q3 revenue to $29.4 billion, and generating $10.26 billion in quarterly free cash flow.

The problem was not business deterioration. The stock had simply run too far, too fast, and was priced for perfection. The recovery accelerated after Broadcom disclosed a multi-year custom chip supply deal with Apple through 2031, later valued at more than $30 billion. That triggered a 5.7% jump and helped the stock reclaim key technical levels.

Broadcom Stock is still around 19–20% below its peak, but the rebound now has a stronger base: The key question is whether that is enough to justify a fresh move back toward all-time highs. Let's break down why the recovery is more structural than a single-catalyst bounce, what is still blocking the path to all-time high, and whether the current level represents a rational entry point for investors.

Why Broadcom Stock Fell: Five Fears That Built a 30% Correction in AVGO

Stock corrections in fundamentally sound businesses do not happen for one reason. They happen when several independent concerns arrive simultaneously and compound each other in investor sentiment. Broadcom's 30% fall from $481.57 to approximately $336 was the result of five distinct fears that were priced in between early June and early July 2026. 

1. Apple defection risk: Apple contributes roughly 20% of Broadcom’s annual revenue, so any shift toward in-house chip design is a real risk. With Apple already building its own A-series, M-series, modem, and N1 Wi-Fi chips, investors feared Broadcom could lose part of a large, predictable revenue stream.
2. Signal of AI capex softening: Broadcom’s Q3 AI chip guidance of $16 billion was $360 million below Wall Street’s $16.36 billion estimate. For a stock trading at 60x+ trailing earnings, even this small miss raised doubts about whether hyperscaler AI spending is cooling and whether Broadcom can hit its $100 billion FY2027 AI revenue target.
3. Customer concentration with no new additions: Broadcom's AI chip revenue was heavily concentrated in three to four hyperscalers: primarily Google, Apple, and Meta. If the next tier of AI infrastructure builders, OpenAI, Anthropic, and others, developed their own silicon independently or worked with Marvell instead, Broadcom's growth runway would face a ceiling.
4. Gross margin compression eating into the quality of earnings: The Q3 gross margin guidance of 74% vs. Q2's 77.1% raised the question of whether Broadcom's premium FCF margins were structurally deteriorating as AI chips, which are lower-margin than software, became a larger share of revenue.
5. Strategic uncertainty from Hock Tan's "chips only" pivot, where the company walked back an earlier commitment to supply integrated AI systems, creating ambiguity about the product roadmap.

The Fear Inventory: Which AVGO Stock Risks Have Eased?

The Fear Inventory framework asks a precise question: of the five fears priced into the correction, how many have been eliminated by data? Each cleared fear should be worth approximately one-fifth of the lost valuation, all else being equal. Three fears have now been substantially resolved. That is why the stock has recovered roughly half its 30% drop.

Fear 1: Apple Defection Risk — ELIMINATED

Apple’s new Broadcom deal removes the biggest customer-risk overhang. The agreement runs through 2031, is worth more than $30 billion, covers custom AI silicon and FBAR wireless filters, and supports production of 15 billion+ chips at Broadcom’s Fort Collins facility. Since Apple contributes roughly 20% of Broadcom’s annual revenue, this turns a major in-sourcing risk into a multi-year secured revenue stream.

Fear 2: AI Capex Softening — SUBSTANTIALLY ADDRESSED

The $360 million AI chip guidance miss that triggered the initial sell-off has been recontextualized by what came with it. Broadcom guided Q3 revenue to $29.4 billion, up 84% year over year and 32% sequentially, with AI semiconductor revenue expected at $16 billion, more than 200% above last year. Hock Tan also maintained the $100 billion FY2027 AI chip revenue target, suggesting the AI demand story is still intact.

Fear 3: No New ASIC Customer Additions — SUBSTANTIALLY ADDRESSED

The “no new customer” concern has weakened meaningfully by three announcements in roughly 30 days. OpenAI’s Jalapeño accelerator, Apple’s expanded AI silicon deal, and Anthropic being named a customer, all point to broader ASIC adoption. That directly challenges the earlier view that Broadcom’s AI opportunity was too concentrated.

Fear 4: Gross Margin Compression — ACTIVE, UNRESOLVED

Guidance of 74% gross margin for Q3, down from 77.1% in Q2, remains an open question. If the trend continues toward 70% or below as AI chips scale further, the FCF model at the current multiple becomes harder to defend. This fear has not cleared. It is the ceiling on the current recovery.

Fear 5: Chips-Only Strategy Uncertainty — PARTIALLY ACTIVE.

No new clarity has emerged since Tan's Q2 call reversal. Minor in isolation, but it adds to the unresolved overhang. At current valuation levels, this is not the primary constraint, but it is not closed either.

The Fear Inventory: AVGO Recovery Tracker (July 9, 2026)

The stock fell 30% when all five fears were active and compounding. Three fears have now cleared or been substantially addressed, which is consistent with the observed recovery of approximately 15-16% from the trough. The remaining unresolved fears are what keep the stock approximately 20% below its all-time high. They also define what must happen for the ATH re-test to materialize.

Why Apple’s $30 Billion Broadcom Deal Matters for AVGO

Apple deal is more than just a customer retention story. The fear that Apple would in-source was an architecture question. If Apple could replace Broadcom's FBAR filters and custom AI silicon in-house, it would prove that Broadcom's technology is commoditized, that a sufficiently large and well-resourced customer could replicate what Broadcom provides. That would change the quality of the entire customer base narrative, not just the Apple line item.

The deal structure answered the architecture question. Apple's expansion of the partnership into custom ASIC silicon, products specifically designed for AI workloads, confirms that even the most technologically sophisticated consumer electronics company in the world has concluded that Broadcom's co-design capabilities cannot be replicated in-house before 2031. 

Apple is basically stating that for the category of silicon it needs most for future product cycles, Broadcom is not replaceable on any near-term timeline. This is the Customization Paradox at work. The more complex and purpose-built the chip, the harder it is to develop an in-house alternative. Apple has proven it can do application processors and modems. It has not proven it can do FBAR filters at production scale or co-design AI inference silicon at the architectural level that Broadcom works at. 

The same logic applies across the customer base. OpenAI co-developed Jalapeño because Broadcom's design capabilities reduce its time-to-production by years. Google has co-developed successive TPU generations through Broadcom rather than doing it fully in-house. Every hyperscaler's attempt to build custom silicon runs through Broadcom's architectural expertise. The Apple deal simply provided the clearest public evidence of this dynamic.

The Gross Margin Percentage Story Is Missing the Cash Story

Here is the number the market is not calculating, and it is the most important original data point in evaluating Broadcom's recovery trajectory. Broadcom's gross margin fell from 77.1% in Q2 to a guided 74% in Q3. The market interprets a 3.1 percentage point decline as a deterioration story. But the relevant question is not what gross margin the company runs at. It is how many gross profit dollars it generates.

The gross margin percentage fell 3.1 points. Gross profit in dollar terms rose by approximately $4.7 billion, or roughly 27%, in a single quarter. The narrative of compression has it backwards. The compression in percentage is being outrun by the expansion in revenue so decisively that the absolute cash generation is accelerating, not slowing.

Gross Profit Dollar Expansion vs. Margin Percentage: The AVGO Mismatch

Sources: Broadcom SEC Form 8-K (June 3, 2026); FY2027 scenarios are estimates based on management-guided AI revenue targets and conservative margin assumptions

Even in the bear case, where Broadcom misses its AI revenue target by 20% and gross margins fall to 70%, the lowest the company has likely been in recent history, absolute gross profit would be approximately $80.5 billion annualized, versus a current $21.8 billion per quarter (approximately $87.2 billion annualized). The bear case is almost identical to the current run rate in gross profit terms, at a revenue level $44 billion higher.

Think of it like how HDFC Bank’s NIM fell from 4.1% to 3.35% after the merger with HDFC Ltd, and investors who tracked only the percentage sold. But absolute net interest income grew as the loan book expanded. Broadcom is running the same dynamic with gross margins and gross profit. The percentage will likely continue to moderate as AI chip revenue becomes a larger share of the mix. The absolute cash generation will continue to grow because revenue growth is far outpacing the margin compression rate.

AVGO Analyst Ratings and Options Market Signals

The Wall Street consensus on AVGO is unusually unified for a $1.8 trillion market cap stock. As of July 7, 2026, S&P Global Market Intelligence aggregates 48 analyst ratings with a Strong Buy consensus: 44 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The average 12-month price target is approximately $523, representing roughly 35-36% upside from current levels. The sole dissent is Erste Group's Hans Engel, who downgraded AVGO stock to Hold on July 7, citing valuation concerns, not a deteriorating business view.

Analyst Scorecard (July 2026)

Sources: Benzinga; StockAnalysis, Broadcom Q2 FY2026 Earnings Call Transcript

The options market offers a different but corroborating signal. Per Barchart data as of July 7, 2026, the put-to-call ratio on AVGO September expiry contracts sits at 0.55x, representing a strongly bullish skew. The upper price on those contracts implies a potential 16%+ move to approximately $438 by mid-September. 

That level is still about 9% below the all-time high of $481.57, but it would represent a 13-14% gain from current levels and a partial clearing of the remaining Fear Inventory overhang if Q3 gross margins hold above 73%.

One critical upcoming event: AVGO needs to hold above the $377-$381 cluster of moving averages. Per FX Leaders technical analysis, AVGO has reclaimed the Ichimoku base line at approximately $385. A sustained break above $400, where the 100-day SMA sits, would mark a technical confirmation of the recovery as more than a single-session move.

Key Risks That Could Limit Broadcom Stock’s Recovery

The bull case for Broadcom stock is clear. These three risks are where it breaks.

Margin risk: If Q3 gross margin falls below 74% and Q4 guidance drops toward 70–71%, the “revenue growth offsets margin compression” case weakens. Gross profit expansion only holds if revenue keeps growing at 80%+ YoY. Q3 results in early September are the first major checkpoint.

AI target risk: Broadcom’s valuation depends heavily on its $100 billion FY2027 AI revenue target. If that target slips by 20% or more to around $80 billion, it would reset growth expectations and likely trigger further multiple compression. Since Hock Tan has repeatedly reiterated the target, any downgrade would also hit management credibility.

VMware risk: Infrastructure software revenue was $7.18 billion in Q2, below the $7.32 billion consensus, with only 9% YoY growth. If VMware churn rises after pricing changes, the software segment could weaken just as chip margins are under pressure. Q3 software guidance of 31% YoY growth needs to prove the margin anchor is still intact.

Our Take on Broadcom: Is It The Right Time To Enter AVGO?

Broadcom’s rebound from 30% below ATH to ~20% below ATH looks more structural than speculative. Three major fears have eased, while the business still shows strong momentum:.

• Bull case: Apple’s deal secures roughly 20% of annual revenue through 2031. Q3 guidance of $16B AI chip revenue (+200%+ YoY) suggests AI demand remains strong, while OpenAI and Anthropic reduce customer-concentration risk.
• Bear case: Margin risk is still unresolved. If Q3 gross margin falls below 74% or Q4 points toward further compression, the recovery weakens. The $100B FY2027 AI revenue target and VMware’s 9% Q2 software growth also need validation.

Data suggests that at $385–390, Broadcom looks more reasonably priced than it did at either extreme. At $481 ATH, the stock priced in perfection. At the $336 trough, all five fears were active. Now, three have eased and two remain.

The entry case also looks stronger because the recovery is backed by new evidence: Apple’s $30B+ commitment through 2031, Q3 revenue guidance of $29.4B, and Wall Street’s 44 Buy/0 Sell rating mix with a $523 average target. For a 12–24 month investor, this is not risk-free, but the risk-reward has improved meaningfully.

The safer approach may be to wait for Q3 gross margin in September. If margin holds at 74%+, the thesis gets cleaner, but the stock may already move higher by then. Current levels might work as a staggered entry point for investors willing to take that margin risk.